Financial reports
NT 10-K
Notice of late annual filing
2 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
Current reports
8-K
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
26 Apr 24
8-K/A
Entry into a Material Definitive Agreement
10 Apr 24
8-K
Entry into a Material Definitive Agreement
2 Apr 24
8-K
Amendments to Articles of Incorporation or Bylaws
21 Mar 24
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
21 Feb 24
8-K/A
Entry into a Material Definitive Agreement
20 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio
1 Feb 24
8-K
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
24 Jan 24
8-K
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration
5 Jan 24
Registration and prospectus
8-A12B
Registration of securities on exchange
14 Feb 24
25-NSE
Exchange delisting
14 Feb 24
425
Business combination disclosure
1 Feb 24
425
Business combination disclosure
31 Jan 24
424B3
Prospectus supplement
24 Jan 24
425
Business combination disclosure
24 Jan 24
424B3
Prospectus supplement
24 Jan 24
424B3
Prospectus supplement
10 Jan 24
425
Business combination disclosure
5 Jan 24
Proxies
DEFR14A
Revised proxy
13 Dec 23
DEF 14A
Definitive proxy
4 Dec 23
PRER14A
Preliminary revised proxy
1 Dec 23
PRER14A
Preliminary revised proxy
27 Nov 23
PRER14A
Preliminary revised proxy
27 Nov 23
PRE 14A
Preliminary proxy
13 Nov 23
DEFA14A
Additional proxy soliciting materials
26 Jan 23
DEF 14A
Definitive proxy
20 Jan 23
PRE 14A
Preliminary proxy
10 Jan 23
Other
CERT
Certification of approval for exchange listing
14 Feb 24
EFFECT
Notice of effectiveness
5 Jan 24
CORRESP
Correspondence with SEC
2 Jan 24
CORRESP
Correspondence with SEC
22 Dec 23
UPLOAD
Letter from SEC
4 Dec 23
UPLOAD
Letter from SEC
4 Dec 23
CORRESP
Correspondence with SEC
27 Nov 23
CORRESP
Correspondence with SEC
21 Nov 23
UPLOAD
Letter from SEC
20 Nov 23
UPLOAD
Letter from SEC
7 Nov 23